November 6, 2023 ImmPACT’s Lupus Drug Fast-Tracked West Hills-based ImmPACT Bio USA Inc. a clinical-stage company developing chimeric antigen receptor T-cell therapies for treating cancer and autoimmune diseases, has received fast-track designation…
